NCT00740519View on ClinicalTrials.gov

Observational Study on Safety of Self-titration of Once Daily Levemir®

CompletedOBSERVATIONAL

Enrollment

882

Participants

Timeline

Start Date

September 30, 2008

Primary Completion Date

March 31, 2011

Study Completion Date

March 31, 2011

Conditions

DiabetesDiabetes Mellitus, Type 2

Interventions

DRUG

insulin detemir

Start dose and frequency to be prescribed by the physician as a result of a normal clinical evaluation.

Trial Locations (1)

RH11 9RT

Novo Nordisk Investigational Site, Crawley

Sponsors

Lead Sponsor

Novo Nordisk A/S

All Listed Sponsors

lead

Novo Nordisk A/S

INDUSTRY